This inventor holds 6 USPTO granted patents and 1 published patent application. Top assignee: Dabur India Limited. Active years: 2005-2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Nadia, IN (2005)
- West Bengal, IN (2005 - 2010)
Company Filing History:
Years Active: 2005-2010
Title: Arun Prakash Sharma: Innovator in Anticancer Taxanes
Introduction
Arun Prakash Sharma is a notable inventor based in West Bengal, India. He has made significant contributions to the field of medicinal chemistry, particularly in the development of anticancer drugs. With a total of 6 patents to his name, Sharma's work is recognized for its innovative approaches to drug formulation.
Latest Patents
One of Sharma's latest patents is titled "Method of preparation of anticancer taxanes using 3-[(substituted-2-trialkylsilyl)ethoxy-carbonyl]-5-oxazolidine carboxylic acids." This invention outlines a detailed process for preparing taxanes, which are crucial in cancer treatment. The method involves several steps, including the coupling of specific intermediates and the treatment of the resulting products to obtain paclitaxel or docetaxel, both of which are vital in oncology.
Career Highlights
Sharma is currently associated with Dabur India Limited, a prominent player in the pharmaceutical and healthcare sector. His work at Dabur has allowed him to focus on innovative drug development, contributing to the company's reputation for quality and efficacy in medicinal products.
Collaborations
Throughout his career, Sharma has collaborated with several talented individuals, including Subrata Sarkar and Jyan Shankar Mahanty. These collaborations have fostered a creative environment that encourages the exchange of ideas and expertise in the field of drug development.
Conclusion
Arun Prakash Sharma's contributions to the field of anticancer drug development are commendable. His innovative methods and collaborative spirit continue to advance the fight against cancer, making a significant impact in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile